Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Dec;76(6):2254–2258. doi: 10.1172/JCI112234

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.

P Charles, J W Poser, L Mosekilde, F T Jensen
PMCID: PMC424348  PMID: 3878367

Abstract

Bone gamma-carboxyglutamic acid-containing (Gla) protein (BGP, osteocalcin) is a noncollagenous protein of bone present in plasma and removed by the kidney. Plasma BGP has been shown to be elevated in patients with certain bone diseases. The present study evaluates serum BGP (S-BGP), serum alkaline phosphatase (S-AP), and urinary hydroxyproline excretion (U-OHP) in diseases with differing bone turnover rates, and compares the accuracy of these measurements for estimating bone mineralization (m) and resorption (r) rates. S-BGP, S-AP, U-OHP, and creatinine clearance (Clcr) were measured in patients with primary hyperparathyroidism (n = 13), hyperthyroidism (n = 6), and hypothyroidism (n = 6). Bone mineralization and resorption rates were calculated from a 7-d combined calcium balance and 47Ca turnover study. A highly significant correlation (r = 0.69, P less than 0.001) was found between S-BGP and m. Multiple regression analysis disclosed a partial correlation between S-BGP and m when Clcr was taken into account (r = 0.82, P less than 0.001), and between S-BGP and Clcr when m was taken into account (r = -0.62, P less than 0.005). In accordance with this, a stronger correlation (r = 0.89, P less than 0.0001) was found between S-BGP X Clcr and m than between S-BGP and m. A less significant correlation was found between S-AP and m (r = 0.45, P less than 0.05). Furthermore, U-OHP showed a highly significant positive correlation to r (r = 0.78, P less than 0.001). Thus, in the studied disorders of calcium metabolism, individual serum levels of BGP depend on both mineralization rate and renal function. Serum levels of BGP corrected for alterations in renal function are superior to uncorrected S-BGP and to S-AP levels in the estimation of bone mineralization rates.

Full text

PDF
2254

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. P., Delmas P. D., Malaval L., Edouard C., Chapuy M. C., Meunier P. J. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet. 1984 May 19;1(8386):1091–1093. doi: 10.1016/s0140-6736(84)92506-6. [DOI] [PubMed] [Google Scholar]
  2. Burkinshaw L., Marshall D. H., Oxby C. B., Spiers F. W., Nordin B. E., Young M. M. Bone turnover model based on a continuously expanding exchangeable calcium pool. Nature. 1969 Apr 12;222(5189):146–148. doi: 10.1038/222146a0. [DOI] [PubMed] [Google Scholar]
  3. Charles P., Jensen F. T., Mosekilde L., Hansen H. H. Calcium metabolism evaluated by 47Ca kinetics: estimation of dermal calcium loss. Clin Sci (Lond) 1983 Oct;65(4):415–422. doi: 10.1042/cs0650415. [DOI] [PubMed] [Google Scholar]
  4. Delmas P. D., Stenner D., Wahner H. W., Mann K. G., Riggs B. L. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest. 1983 May;71(5):1316–1321. doi: 10.1172/JCI110882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Delmas P. D., Wilson D. M., Mann K. G., Riggs B. L. Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab. 1983 Nov;57(5):1028–1030. doi: 10.1210/jcem-57-5-1028. [DOI] [PubMed] [Google Scholar]
  6. Frost H. M. Tetracycline-based histological analysis of bone remodeling. Calcif Tissue Res. 1969;3(3):211–237. doi: 10.1007/BF02058664. [DOI] [PubMed] [Google Scholar]
  7. Hauschka P. V., Lian J. B., Gallop P. M. Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3925–3929. doi: 10.1073/pnas.72.10.3925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jensen F. T., Charles P., Mosekilde L., Hansen H. H. Calcium metabolism evaluated by 47calcium-kinetics: a physiological model with correction for faecal lag time and estimation of dermal calcium loss. Clin Physiol. 1983 Apr;3(2):187–204. doi: 10.1111/j.1475-097x.1983.tb00690.x. [DOI] [PubMed] [Google Scholar]
  9. KLEIN L., LAFFERTY F. W., PEARSON O. H., CURTISS P. H., Jr CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER. Metabolism. 1964 Mar;13:272–284. doi: 10.1016/0026-0495(64)90106-4. [DOI] [PubMed] [Google Scholar]
  10. Laitinen O. Clinical applications of urinary hydroxyproline determination. Acta Med Scand Suppl. 1975;577:1–57. [PubMed] [Google Scholar]
  11. Mosekilde L., Melsen F. Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Pathol Microbiol Scand A. 1978 Jan;86(1):56–62. doi: 10.1111/j.1699-0463.1978.tb02012.x. [DOI] [PubMed] [Google Scholar]
  12. Nishimoto S. K., Price P. A. Secretion of the vitamin K-dependent protein of bone by rat osteosarcoma cells. Evidence for an intracellular precursor. J Biol Chem. 1980 Jul 25;255(14):6579–6583. [PubMed] [Google Scholar]
  13. Poser J. W., Esch F. S., Ling N. C., Price P. A. Isolation and sequence of the vitamin K-dependent protein from human bone. Undercarboxylation of the first glutamic acid residue. J Biol Chem. 1980 Sep 25;255(18):8685–8691. [PubMed] [Google Scholar]
  14. Price P. A., Nishimoto S. K. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2234–2238. doi: 10.1073/pnas.77.4.2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Price P. A., Otsuka A. A., Poser J. W., Kristaponis J., Raman N. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A. 1976 May;73(5):1447–1451. doi: 10.1073/pnas.73.5.1447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Price P. A., Parthemore J. G., Deftos L. J. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest. 1980 Nov;66(5):878–883. doi: 10.1172/JCI109954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Price P. A., Poser J. W., Raman N. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3374–3375. doi: 10.1073/pnas.73.10.3374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Price P. A., Williamson M. K., Lothringer J. W. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem. 1981 Dec 25;256(24):12760–12766. [PubMed] [Google Scholar]
  19. Reeve J., Wootton R., Hesp B. A new method for calculating the accretion rate of bone calcium and some observations on the suitability of strontium-85 as a tracer for bone calcium. Calcif Tissue Res. 1976 Apr 20;(2):121–135. doi: 10.1007/BF02546402. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES